A Study of Consent Forms for Whole Exome and Whole Genome Sequencing
| Status: | Suspended |
|---|---|
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/27/2019 |
| Start Date: | August 20, 2013 |
| End Date: | March 10, 2020 |
Randomized Trial of Consent Interventions for NIH Whole Exome and Whole Genome Sequencing Studies
Background:
The purpose of this study is to investigate the process of consenting participants to whole
exome/genome sequencing and its outcomes. It is unknown how best to consent people to this
new technology. NO GENOME SEQUENCING IS OFFERED AS PART OF THIS STUDY. This protocol is a
companion to other NIH studies that involve genomic sequencing. Participants must be enrolled
in a parent NIH study that is collaborating on this consent study to be eligible. Currently
this involves only one NIH study.
Objectives:
- To learn the best way to help participants understand sequencing, so they can decide
whether to join studies that use it.
Eligibility:
- Adults at least 18 years old who are enrolled in a National Institutes of Health (NIH)
study that uses WES/WGS.
- Adults at least 18 years old whose children are enrolled in an NIH study that uses
WES/WGS.
Design:
- Participants will take part in the study either in person or over the phone.
- Participants will review two sequencing consent forms with a genetic counselor.
- Before and after meeting with the counselor, participants will answer several questions
about sequencing. Each questionnaire will take about 15 minutes.
- Six weeks later, participants will answer questions about sequencing. This will take
about 15 minutes.
The purpose of this study is to investigate the process of consenting participants to whole
exome/genome sequencing and its outcomes. It is unknown how best to consent people to this
new technology. NO GENOME SEQUENCING IS OFFERED AS PART OF THIS STUDY. This protocol is a
companion to other NIH studies that involve genomic sequencing. Participants must be enrolled
in a parent NIH study that is collaborating on this consent study to be eligible. Currently
this involves only one NIH study.
Objectives:
- To learn the best way to help participants understand sequencing, so they can decide
whether to join studies that use it.
Eligibility:
- Adults at least 18 years old who are enrolled in a National Institutes of Health (NIH)
study that uses WES/WGS.
- Adults at least 18 years old whose children are enrolled in an NIH study that uses
WES/WGS.
Design:
- Participants will take part in the study either in person or over the phone.
- Participants will review two sequencing consent forms with a genetic counselor.
- Before and after meeting with the counselor, participants will answer several questions
about sequencing. Each questionnaire will take about 15 minutes.
- Six weeks later, participants will answer questions about sequencing. This will take
about 15 minutes.
Consent to participant in studies that include whole exome and whole genome sequencing
(WES/WGS) studies and to receive results present challenges to achieving informed consent due
to the scope, depth and uncertainty of the information. NIH Intramural studies increasingly
involve WES/WGS to identify elusive primary variants. This umbrella protocol aims to compare
an evidence-based consent for WES/WGS to a standard consent in collaboration with ongoing and
future NIH studies. An equivocal hypothesis will be tested to evaluate whether informed
choice and perceptions of uncertainty differ between two consent
groups. A mixed-methods design is proposed that starts with a qualitative mental-model pilot
study to revise an expert opinion consent intervention by integrating lay-person response
preferences. Following development of this evidence-based intervention, a randomized two-
factor design will be used for a quantitative survey study conducted in conjunction with a
number of NIH studies conducting WES/WGS to test for differences between two consent
models. A descriptive analysis of the audiotaped consent process will also be conducted to
assess differences in the content or extent of the process, and related outcomes of
satisfaction and decisional conflict will also be assessed.
(WES/WGS) studies and to receive results present challenges to achieving informed consent due
to the scope, depth and uncertainty of the information. NIH Intramural studies increasingly
involve WES/WGS to identify elusive primary variants. This umbrella protocol aims to compare
an evidence-based consent for WES/WGS to a standard consent in collaboration with ongoing and
future NIH studies. An equivocal hypothesis will be tested to evaluate whether informed
choice and perceptions of uncertainty differ between two consent
groups. A mixed-methods design is proposed that starts with a qualitative mental-model pilot
study to revise an expert opinion consent intervention by integrating lay-person response
preferences. Following development of this evidence-based intervention, a randomized two-
factor design will be used for a quantitative survey study conducted in conjunction with a
number of NIH studies conducting WES/WGS to test for differences between two consent
models. A descriptive analysis of the audiotaped consent process will also be conducted to
assess differences in the content or extent of the process, and related outcomes of
satisfaction and decisional conflict will also be assessed.
- INCLUSION CRITERIA:
Eligible adults (greater than or equal to 18 years of age) consenting to enroll in an NIH
study that includes WES/WGS. Parents of eligible children (<18 years of age) consenting to
enroll their child(ren) in an NIH study that includes WES/WGS. Participants must be
cognitively able to consent and fluent in written and spoken English.
EXCLUSION CRITERIA:
Children (<18 years of age). Non-English speaking participants (until the study has evolved
to be able to use translations of the interventions into Spanish).
We found this trial at
1
site
9000 Rockville Pike
Bethesda, Maryland 20892
Bethesda, Maryland 20892
Phone: 800-411-1222
Click here to add this to my saved trials
